Anonymous ID: 46c77a Oct. 3, 2021, 5:54 p.m. No.14714410   🗄️.is 🔗kun

>>14714338

Remember, apollo 8 circled the moon and they showed all kinds of film and pictures of the moon, but never once aimed the camera out the window back at the earth.

Anonymous ID: 46c77a Oct. 3, 2021, 6:05 p.m. No.14714490   🗄️.is 🔗kun   >>4556 >>4716

>>14714350

Ivermectin and Panacur C are both made by Merck. HCQ Plaquenil is made by Sanofi Aventis. But then there's this: Merck sells its 50% of Merial to Sanofi-Aventis

30-07-2009 | Home | News

FacebookTwitterLinkedInEmailPrint

Merck sells its 50% of Merial to Sanofi-Aventis

French pharmaceutical company Sanofi-Aventis will acquire Merck’s interest in animal health company Merial, the companies announced on Thursday, July 30.

 

 

 

 

The companies signed a definitive agreement under which Merck will sell its 50% interest in the companies’ current animal health joint venture, Lyon, France-based Merial, to Sanofi-Aventis for US$4 billion in cash.

 

A decision about the future of Merial was expected since Merck and Schering-Plough announced a merger in early March. The companies’ animal health divisions (Merial and Intervet/Schering-Plough Animal Health) are both seeded in the global animal health top-three – and a combined animal health division will be the world’s largest with a combined turnover of more than $5 billion annually.

 

 

Call-option agreement

Merck, Sanofi-Aventis and Schering-Plough also announced a call option agreement, which would include that following the closing of the Merck/Schering-Plough merger, Sanofi-Aventis would have an option to combine the Intervet/Schering-Plough Animal Health business with Merial to form an animal health joint venture that would be owned equally by the new Merck and Sanofi-Aventis.

 

"These agreements should enable us to proceed expeditiously with the closing of our merger with Schering-Plough in the fourth quarter as planned, and also gain an outstanding animal health business through Intervet/Schering-Plough Animal Health," said Richard T. Clark, Merck chairman, president and chief executive officer.

 

"We are pleased that our long-time partner Sanofi-Aventis will purchase Merck’s interest in Merial, the successful joint venture we built together," he added. "We look forward to the potential opportunity to bring together the strong animal health businesses of Sanofi-Aventis

Anonymous ID: 46c77a Oct. 3, 2021, 6:40 p.m. No.14714707   🗄️.is 🔗kun

There is another big company in the world that has an animal health division, Bayer, but you haven't heard much from them since they committed suicide with Monsanto. Remember Bayer is the maker of Cipro, the antibiotic that was prescribed after the anthrax attacks after 911.